
Ikvarab-D Tablet
Marketer
Ikvans Pharma
Salt Composition
Domperidone (10mg) + Rabeprazole (20mg)
Overview Ikvarab-D Tablet
Gastroesophageal reflux disease (GERD, or acid reflux) can be effectively managed with Ikvarab-D Tablets, a combination medication. This treatment alleviates common GERD symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion, thus easing discomfort. Ikvarab-D should be taken on an empty stomach, following your doctor's prescribed dosage and duration. Your individualized dosage depends on your condition and response to the medication. Consistent use, as directed by your physician, is crucial; premature discontinuation might lead to symptom recurrence and disease exacerbation. Inform your healthcare provider of all other medications you are currently using, as interactions are possible. Common, typically transient, side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects to your doctor immediately. Drowsiness and dizziness are potential side effects; avoid driving or activities requiring alertness until the drug's effects are known. Alcohol consumption should be avoided due to potential additive drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding caffeinated beverages, spicy foods, and chocolate, may enhance treatment outcomes. Prior to commencing treatment, inform your doctor of any existing kidney or liver conditions, pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Ikvarab-D Tablet
No text provided. Please provide the text you would like me to rephrase.
Uses of Ikvarab-D Tablet
Managing acid reflux and peptic ulcers.
Major Benefits of Ikvarab-D Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Ikvarab-D Tablet on an empty stomach.
Common Side effects of Ikvarab-D Tablet:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Ikvarab-D Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Ikvarab-D Tablet on an empty stomach.
How Ikvarab-D Tablet works:
Ikvarab-D Tablets contain Domperidone and Rabeprazole, two active ingredients with complementary actions. Domperidone, a prokinetic agent, enhances gastrointestinal motility, facilitating smoother passage of food through the stomach and intestines. Rabeprazole, a proton pump inhibitor (PPI), decreases gastric acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
It's recommended to avoid alcohol while taking Ikvarab-D Tablets. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Ikvarab-D tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Ikvarab-D Tablet use may pose a risk. Available human data indicates potential drug transfer to breast milk, possibly harming the infant.
DrivingUNSAFE
Driving should be avoided if you experience drowsiness, dizziness, blurred vision, or reduced alertness after taking Ikvarab-D Tablets. These side effects are possible.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Ikvarab-D Tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Ikvarab-D tablets cautiously, potentially requiring dose modification. Physician consultation is advised. Ikvarab-D tablets are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Ikvarab-D Tablet :
Should you forget to take your Ikvarab-D Tablet, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ikvarab-D Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
